scholarly article | Q13442814 |
P2093 | author name string | K S Kosik | |
A Andreadis | |||
J A Broderick | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
A comprehensive set of sequence analysis programs for the VAX | Q26778432 | ||
Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination | Q27860827 | ||
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease | Q28910345 | ||
Primary structure of high molecular weight tau present in the peripheral nervous system | Q30989380 | ||
Generation of protein isoform diversity by alternative splicing: mechanistic and biological implications | Q34559928 | ||
Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains | Q35199848 | ||
Branch point selection in alternative splicing of tropomyosin pre-mRNAs | Q35236930 | ||
Developmentally regulated expression of specific tau sequences | Q35545934 | ||
Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites | Q35832261 | ||
Nucleotide substitutions within the cardiac troponin T alternative exon disrupt pre-mRNA alternative splicing | Q35948813 | ||
The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element | Q36686833 | ||
Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns | Q36695561 | ||
Elements regulating an alternatively spliced exon of the rat fibronectin gene | Q36698617 | ||
Identification of a novel neuronal C-SRC exon expressed in human brain | Q36708131 | ||
Myosin light-chain 1/3 gene alternative splicing: cis regulation is based upon a hierarchical compatibility between splice sites | Q36708440 | ||
Exon definition may facilitate splice site selection in RNAs with multiple exons | Q36713104 | ||
Combinatorial splicing of exon pairs by two-site binding of U1 small nuclear ribonucleoprotein particle | Q36742725 | ||
Selection of splice sites in pre-mRNAs with short internal exons | Q36743676 | ||
The 216-nucleotide intron of the E1A pre-mRNA contains a hairpin structure that permits utilization of unusually distant branch acceptors | Q36795093 | ||
Cooperation of pre-mRNA sequence elements in splice site selection | Q36814763 | ||
In vivo splicing of the beta tropomyosin pre-mRNA: a role for branch point and donor site competition | Q36819496 | ||
Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements | Q36823020 | ||
Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system | Q36872830 | ||
Biochemical Mechanisms of Constitutive and Regulated Pre-mRNA Splicing | Q37132263 | ||
Tau protein: an update on structure and function | Q37812393 | ||
Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice | Q38335787 | ||
Microtubule-associated proteins: their potential role in determining neuronal morphology | Q39639380 | ||
Split genes and RNA splicing | Q40389967 | ||
A sequence compilation and comparison of exons that are alternatively spliced in neurons | Q40399515 | ||
The exon trapping assay partly discriminates against alternatively spliced exons | Q40406902 | ||
Effect of 5' splice site mutations on splicing of the preceding intron | Q40647569 | ||
Alternative splicing of beta-tropomyosin pre-mRNA: cis-acting elements and cellular factors that block the use of a skeletal muscle exon in nonmuscle cells | Q41169568 | ||
Does steric interference between splice sites block the splicing of a short c-src neuron-specific exon in non-neuronal cells? | Q41179531 | ||
Alternative splicing in the neural cell adhesion molecule pre-mRNA: regulation of exon 18 skipping depends on the 5'-splice site. | Q41671462 | ||
A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. | Q41689368 | ||
Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. | Q41746563 | ||
In Vivo Recognition of a Vertebrate Mini-Exon as an Exon-Intron-Exon Unit | Q41967909 | ||
Scanning from an independently specified branch point defines the 3' splice site of mammalian introns | Q43653965 | ||
Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element | Q48081411 | ||
Structure and novel exons of the human tau gene | Q48149325 | ||
Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor. | Q48175140 | ||
Mutually exclusive splicing of alpha-tropomyosin exons enforced by an unusual lariat branch point location: implications for constitutive splicing | Q48302007 | ||
The role of exon sequences in splice site selection. | Q52545848 | ||
Alternative splicing of tropomyosin pre-mRNAs in vitro and in vivo | Q68013184 | ||
Activation of c-src neuron-specific splicing by an unusual RNA element in vivo and in vitro | Q68133924 | ||
Alternative splicing of SV40 early pre-mRNA is determined by branch site selection | Q69846391 | ||
Splicing of SV40 early pre-mRNA to large T and small t mRNAs utilizes different patterns of lariat branch sites | Q70182088 | ||
The role of the mammalian branchpoint sequence in pre-mRNA splicing | Q70232865 | ||
Microtubule-bundling studies revisited: is there a role for MAPs? | Q75293928 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3585-3593 | |
P577 | publication date | 1995-09-01 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons | |
P478 | volume | 23 |
Q34478778 | A novel isoform of the mitochondrial outer membrane protein VDAC3 via alternative splicing of a 3-base exon. Functional characteristics and subcellular localization |
Q89493910 | Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease |
Q39891392 | Altered splicing of Tau in DM1 is different from the foetal splicing process. |
Q51978000 | Complex regulation of tau exon 10, whose missplicing causes frontotemporal dementia. |
Q26829183 | Curcuminoids and resveratrol as anti-Alzheimer agents |
Q35999257 | Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT |
Q46284976 | Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy |
Q36271734 | Evidence for disulfide bonds in SR Protein Kinase 1 (SRPK1) that are required for activity and nuclear localization |
Q36003798 | Gene-environment interplay in neurogenesis and neurodegeneration |
Q43287320 | Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders. |
Q92052406 | Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies |
Q41872983 | Ketamine induces tau hyperphosphorylation at serine 404 in the hippocampus of neonatal rats |
Q48216899 | Modulation of the membrane-binding domain of tau protein: splicing regulation of exon 2. |
Q48607335 | Modulation of the membrane-binding projection domain of tau protein: splicing regulation of exon 3. |
Q41379250 | Normal and pathological Tau proteins as factors for microtubule assembly. |
Q46509884 | Overexpression of dishevelled-1 attenuates wortmannin-induced hyperphosphorylation of cytoskeletal proteins in N2a cell. |
Q36076343 | Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer's disease |
Q53288818 | Single molecule profiling of tau gene expression in Alzheimer's disease. |
Q36789895 | Tau exon 10 alternative splicing and tauopathies |
Q28306183 | Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c.SRp55 complex that either recruits or antagonizes htra2beta1 |
Q36003810 | Tau in neurodegenerative diseases: tau phosphorylation and assembly |
Q48498752 | Tau isoforms expression in transgenic mouse model of amyotrophic lateral sclerosis. |
Q57897029 | Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work |
Q28140466 | The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites |
Q33883223 | The in vivo minigene approach to analyze tissue-specific splicing |
Q42157266 | The involvement of cholinergic neurons in the spreading of tau pathology. |
Q47693846 | The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration |
Q38307434 | The splicing determinants of a regulated exon in the axonal MAP tau reside within the exon and in its upstream intron |
Search more.